Renal Cell A031704

Study #A031704

PD-inhibitor (Nivolumab) and Ipilimumab followed by nivolumab vs. VEGF TKI cabozantinib with nivolumab in metastatic untreated REnal Cell CancEr [PDIGREE]

Back To Clinical Trials NCI Database Entry